Notice of Closed Meeting, 1584 [2023-00242]
Download as PDF
<![CDATA[
1584
Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices
Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS H21–10, Atlanta, Georgia
30329–4027, Telephone: (404) 639–
0390; Email Address: ACDirector@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to
the Director (ACD), CDC, shall advise
the Secretary, HHS, and the Director,
CDC, on policy and broad strategies that
will enable CDC to fulfill its mission of
protecting health through health
promotion, prevention, and
preparedness. The committee
recommends ways to prioritize CDC’s
activities, improve results, and address
health disparities. It also provides
guidance to help CDC work more
effectively with its various private and
public sector constituents to make
health protection a practical reality.
Matters To Be Considered: The
agenda will include discussions on
CDC’s current work and priorities as
they relate to health equity and data and
surveillance recommendations to the
Department of Health and Human
Services and CDC Director. The agenda
also includes a laboratory workgroup
update with recommended action steps
to the full ACD Committee, along with
an update on the public health
infrastructure grant. Agenda items are
subject to change as priorities dictate.
lotter on DSK11XQN23PROD with NOTICES1
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
VerDate Sep<11>2014
17:17 Jan 10, 2023
Jkt 259001
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–00408 Filed 1–10–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–IP–23–001, Public Health
Epidemiology, Prevention and Control
of Influenza and Other Respiratory
Pathogens in China, RFA–IP–23–004,
Developing, Implementing, and
Evaluating Protocols to Increase Routine
Adult Immunization Coverage Among
Persons Who are Incarcerated, and
RFA–IP–23–005, Approach to Adult
Vaccine Counseling.
Date: April 11–12, 2023.
Time: 10 a.m.–5 p.m., EDT.
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1077, 8 Corporate Boulevard, Atlanta,
Georgia 30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Frm 00029
Fmt 4703
Sfmt 4703
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–00242 Filed 1–10–23; 8:45 am]
Notice of Closed Meeting
PO 00000
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, CDC, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329–4027; Telephone: (404)
718–8833; Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[60Day–23–0063; Docket No. ATSDR–2022–
0007]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), as part of its continuing effort
to reduce public burden and maximize
the utility of government information,
invites the general public and other
federal agencies the opportunity to
comment on a continuing information
collection, as required by the Paperwork
Reduction Act of 1995. This notice
invites comment on a proposed
information collection project titled
Human Health Effects of Drinking Water
Exposures to Per- and Polyfluoroalkyl
Substances (PFAS): A Multi-site Crosssectional Study (The Multi-site Study).
The purpose of this research is to use
sound study methods to see if drinking
water exposure to PFAS is related to
health outcomes.
DATES: ATSDR must receive written
comments on or before March 13, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. ATSDR–2022–
0007 by either of the following methods:
SUMMARY:
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Page 1584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00242]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--RFA-IP-23-001, Public Health
Epidemiology, Prevention and Control of Influenza and Other Respiratory
Pathogens in China, RFA-IP-23-004, Developing, Implementing, and
Evaluating Protocols to Increase Routine Adult Immunization Coverage
Among Persons Who are Incarcerated, and RFA-IP-23-005, Approach to
Adult Vaccine Counseling.
Date: April 11-12, 2023.
Time: 10 a.m.-5 p.m., EDT.
Place: Teleconference, Centers for Disease Control and Prevention,
Room 1077, 8 Corporate Boulevard, Atlanta, Georgia 30329.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1,
Atlanta, Georgia 30329-4027; Telephone: (404) 718-8833; Email:
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-00242 Filed 1-10-23; 8:45 am]
BILLING CODE 4163-18-P
